# Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

> **NCT05032859** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 406 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** tapinarof cream, 1%
- **DRUG:** vehicle cream

## Key facts

- **NCT ID:** NCT05032859
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-23
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-08
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032859, "Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05032859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*